Literature DB >> 6447166

Heterogeneity of b lymphocyte differentiation in severe combined immunodeficiency disease.

S G Pahwa, R N Pahwa, R A Good.   

Abstract

Pokeweed mitogen-induced B lymphocyte differentiation in vitro into antibody secreting plaque-forming cells (PFC) was investigated in nine patients with severe combined immunodeficiency having variable proportions of circulating B lymphocytes. When cultured by themselves, the peripheral blood mononuclear cells did not respond to stimulation with pokeweed mitogen in any patient. In the presence of irradiated allogeneic T cells as helpers, however, PFC responses were elicited in lymphocyte cultures from peripheral blood and/or bone marrow in some patients. In one of these patients, results of allogeneic co-culture experiments were suggestive of genetically restricted suppressor cells. In a single patient with deficiency of the enzyme adenosine deaminase, PFC were generated in bone marrow lymphocyte cultures only when they were supplemented with exogenous adenosine deaminase and allogeneic helper cells. A parallel study of T lymphocyte differentiation in vitro performed in fractionated bone marrow cells was suggestive of arrested differentiation at different steps along the differentiation pathway. In two patients with evidence of functional B cell precursors, deficiencies of helper T cell function could be attributed to differentiation defects at the level of the stem cells in one and the thymus in the other. The findings reported here further substantiate the heterogeneity of the severe combined immunodeficiency disease syndromes.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6447166      PMCID: PMC371683          DOI: 10.1172/JCI109886

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  31 in total

1.  Correction of severe combined immunodeficiency by fetal liver cells.

Authors:  R H Buckley; K J Whisnant; R I Schiff; R B Gilbertsen; A T Huang; M S Platt
Journal:  N Engl J Med       Date:  1976-05-13       Impact factor: 91.245

2.  Differentiation of human bone marrow cells into T lymphocytes by in vitro incubation with thymic extracts.

Authors:  J L Touraine; G S Incefy; F Touraine; Y M Rho; R A Good
Journal:  Clin Exp Immunol       Date:  1974-05       Impact factor: 4.330

3.  Human lymphocyte-sheep erythrocyte rosette formation: some characteristics of the interaction.

Authors:  Z Bentwich; S D Douglas; F P Siegal; H G Kunkel
Journal:  Clin Immunol Immunopathol       Date:  1973-07

4.  Successful treatment of an infant with severe combined immunodeficiency by transplantation of bone marrow cells from an uncle.

Authors:  J M Vossen; J de Koning; D W van Bekkum; K A Dicke; V P Eysvoogel; W Hijmans; E van Loghem; J Rádl; J J van Rood; D van der Waay; L J Dooren
Journal:  Clin Exp Immunol       Date:  1973-01       Impact factor: 4.330

5.  Enhanced binding of neuraminidase-treated sheep erythrocytes to human T lymphocytes.

Authors:  M S Weiner; C Bianco; V Nussenzweig
Journal:  Blood       Date:  1973-12       Impact factor: 22.113

6.  Adenosine-deaminase deficiency in two patients with severely impaired cellular immunity.

Authors:  E R Giblett; J E Anderson; F Cohen; B Pollara; H J Meuwissen
Journal:  Lancet       Date:  1972-11-18       Impact factor: 79.321

7.  Separation of cells by velocity sedimentation.

Authors:  R G Miller; R A Phillips
Journal:  J Cell Physiol       Date:  1969-06       Impact factor: 6.384

8.  Demonstration of an intrathymic defect in a case of severe combined immunodeficiency disease.

Authors:  K W Pyke; H Dosch; M M Ipp; E W Gelfand
Journal:  N Engl J Med       Date:  1975-08-28       Impact factor: 91.245

9.  Antigen-specific T-cell factor in cell cooperation and genetic control of the immune response.

Authors:  M J Taussig; A J Munro
Journal:  Fed Proc       Date:  1976-07

10.  Restoration of in-vitro lymphocyte responses with exogenous adenosine deaminase in a patient with severe combined immunodeficiency.

Authors:  S H Polmar; E M Wetzler; R C Stern; R Hirschhorn
Journal:  Lancet       Date:  1975-10-18       Impact factor: 79.321

View more
  8 in total

Review 1.  Genetics of human X-linked immunodeficiency diseases.

Authors:  R W Hendriks; R K Schuurman
Journal:  Clin Exp Immunol       Date:  1991-08       Impact factor: 4.330

2.  Recombinant interleukin 2 therapy in severe combined immunodeficiency disease.

Authors:  R Pahwa; T Chatila; S Pahwa; C Paradise; N K Day; R Geha; S A Schwartz; H Slade; N Oyaizu; R A Good
Journal:  Proc Natl Acad Sci U S A       Date:  1989-07       Impact factor: 11.205

3.  Defective expression of T cell-associated glycoprotein in severe combined immunodeficiency.

Authors:  L K Jung; S M Fu; T Hara; N Kapoor; R A Good
Journal:  J Clin Invest       Date:  1986-03       Impact factor: 14.808

4.  Nonrandom X chromosome inactivation in B cells from carriers of X chromosome-linked severe combined immunodeficiency.

Authors:  M E Conley; A Lavoie; C Briggs; P Brown; C Guerra; J M Puck
Journal:  Proc Natl Acad Sci U S A       Date:  1988-05       Impact factor: 11.205

5.  Lymphocyte subpopulations in primary immunodeficiency disorders.

Authors:  S Gupta
Journal:  Indian J Pediatr       Date:  1982 May-Jun       Impact factor: 1.967

6.  Severe combined immunodeficiency: treatment by bone marrow transplantation in 15 infants using HLA-haploidentical donors.

Authors:  W Friedrich; S F Goldmann; W Ebell; R Blütters-Sawatzki; G Gaedicke; A Raghavachar; H H Peter; B Belohradsky; W Kreth; B Kubanek
Journal:  Eur J Pediatr       Date:  1985-07       Impact factor: 3.183

7.  Prematurity, hypogammaglobulinemia, and neuropathology with human immunodeficiency virus (HIV) infection.

Authors:  R Pahwa; R A Good; S Pahwa
Journal:  Proc Natl Acad Sci U S A       Date:  1987-06       Impact factor: 11.205

8.  Abnormalities in DNA rearrangements of immunoglobulin gene loci in precursor B cells derived from X-linked agammaglobulinemia patient and a severe combined immunodeficiency patient.

Authors:  Y Ichihara; H Matsuoka; I Tsuge; J Okada; S Torii; H Yasui; Y Kurosawa
Journal:  Immunogenetics       Date:  1988       Impact factor: 2.846

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.